https://www.novumpr.nl/2018/06/04/results-of-phase-iii-relevance-study-comparing-revlimid-plus-rituximab-r2-versus-rituximab-plus-chemotherapy-in-patients-with-previously-untreated-follicular-lymphoma-to-be-presented-at-asco-2018/?utm_source=rss&utm_medium=rss&utm_campaign=results-of-phase-iii-relevance-study-comparing-revlimid-plus-rituximab-r2-versus-rituximab-plus-chemotherapy-in-patients-with-previously-untreated-follicular-lymphoma-to-be-presented-at-asco-2018 NovumPR press releases Mon, 04 Jun 2018 08:19:19 +0000 hourly 1 https://wordpress.org/?v=6.8.3